SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-039603
Filing Date
2024-10-04
Accepted
2024-10-04 19:40:56
Documents
1
Period of Report
2024-10-02

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3487
  Complete submission text file 0001493152-24-039603.txt   5122
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Issuer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address C/O ONCOCYTE CORPORATION 15 CUSHING IRVINE CA 92618
Business Address
James Andrea S. (Reporting) CIK: 0002027010 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37648 | Film No.: 241355917